COVID-19 Resources

Health officials determine that the vaccine is safe and effective for preventing COVID-19.

The CDC and FDA recommended a pause on the administration of Janssen’s Johnson & Johnson one-dose COVID-19 vaccine while health authorities review rare blood clotting cases.

Supply chain is working with manufacturers to increase our supply.

CDC released studies emphasizing importance of filtration and well-fitting masks to prevent spread of infection and exposure to COVID-19.

The Johnson & Johnson vaccine marks the third candidate for Emergency Use Authorization.

With an increasing number of caregivers and patients now vaccinated, it’s important to remember that everyone still needs to continue to follow COVID-19 safety practices.

As you prepare to receive your second dose of COVID-19 vaccine, the following tips and reminders will improve your experience.

A new coronavirus strain, first detected in the United Kingdom, has made its way to the U.S. with confirmed cases reported in several states.

Please review the eligibility requirements prior to receiving the COVID-19 vaccine.

Watch Rod’s vaccine Town Hall and read his message about caregiver benefits.

We can begin offering vaccine to our highest-risk, front-line caregivers soon.

The decision was made after an FDA advisory committee reviewed and validated data showing the vaccine to be safe and highly effective.

Because we are expecting a limited supply initially, the first vaccinations will be based on risk, role and work location.

To help us plan distribution of the first doses of the COVID-19 vaccine, we are asking you to complete our online Validate and Verify (VAV) tool.

At least two COVID-19 vaccines are expected to receive FDA emergency use authorization in a matter of days.

Providence offers a glimpse into the current state of developing a COVID-19 vaccine.

Providence is preparing caregivers for the rollout of the COVID-19 vaccine. Learn more about the organization's rollout plan.